Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2008
10/30/2008WO2008024832A3 Methods for isolating and using pituitary adenoma stem cells and pituitary adenoma cells
10/30/2008WO2008022278A3 Atypical pkc mediates wnt signaling in growth cone guidance
10/30/2008WO2008022253A3 An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
10/30/2008WO2008013863A3 Generation of adipose tissue and adipocytes
10/30/2008WO2008002996A3 Rheumatoid arthritis t cell vaccine
10/30/2008WO2007149447A3 Lung progenitor cells, assays, and uses thereof
10/30/2008WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof
10/30/2008WO2007078599A8 Functional arrays for high throughput characterization of gene expression regulatory elements
10/30/2008WO2006083797A3 Improving and protecting cell therapy for neurological disorders including parkinson's disease
10/30/2008WO2005111204A3 Porcine forssman synthetase cdna and polypeptide
10/30/2008WO2004087735A3 Proteolytic and covalent antibodies
10/30/2008US20080271212 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence
10/30/2008US20080271210 Oryza Sativa Lectin-Like Receptor Kinase 1 (Oslrk1), a Gene Involved in Plant Development
10/30/2008US20080271207 Lipase Polypeptide
10/30/2008US20080271206 Monocotyledon promoter sequences for use as tools to enhance heterologous gene expression in plants
10/30/2008US20080271205 Cytochrome p450 for use as tool to increase stevoside concentration in plant cells; identifying and manufature of sugar substitutes; artificial sweetners
10/30/2008US20080271204 Soybean Cultivar 17731225
10/30/2008US20080271203 Transgenic seed for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/30/2008US20080271202 Soybean Cultivar S060294
10/30/2008US20080271201 Transgenic seed for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/30/2008US20080271188 Plants and seeds of corn variety cv202909
10/30/2008US20080271187 Transgenic propagule for generation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/30/2008US20080271186 Plants and seeds of corn variety cv552643
10/30/2008US20080271184 Plants and seeds of corn variety cv592780
10/30/2008US20080271183 Plants and seeds of corn variety cv402930
10/30/2008US20080271182 Plants and seeds of corn variety cv341132
10/30/2008US20080271179 Transgenic propagule for generation of disease, insect and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops
10/30/2008US20080271178 Plants and seeds of corn variety cv227310
10/30/2008US20080271177 Plants and seeds of corn variety cv988815
10/30/2008US20080271175 Plants and seeds of corn variety cv107099
10/30/2008US20080271174 Plants and seeds of corn variety cv886161
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080271166 Polypeptide for use as highly efficient gene targeting tool in mammalian cells
10/30/2008US20080270283 Electronic trading data integration and protection system
10/30/2008US20080269474 Using short hairpin RNA (shRNA) for treatment of cell proliferative disorders; gene expression inhibition
10/30/2008US20080269473 Expression vector comprising nucleotide sequences coding gag and pol proteins for as tool in improving exogenous gene expression
10/30/2008US20080269472 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair
10/30/2008US20080269317 Compounds for Covalent Binding to MD-2 and Effect on the Immune Response
10/30/2008US20080269309 Phosphoinositide-dependent kinase-1 (PDK-1) inhibitors; for the treatment and prevention of cancer in humans; 4-[5-(2-Phenanthracenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenecarboxamide
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269272 Anticancer agents; psoriasis; prevent activation of hedgehog gene passageways
10/30/2008US20080269245 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
10/30/2008US20080269206 Cftr inhibitor compounds and uses thereof
10/30/2008US20080269191 Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases
10/30/2008US20080269163 Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis
10/30/2008US20080269161 Compositions and Methods Relating to Mitochondrial Hyperpolarization in Neurological Disease
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269142 Endogenous thiadiazabicyclo glutathione-adduct
10/30/2008US20080269140 Conformationally Constrained Smac Mimetics and the Uses Thereof
10/30/2008US20080269129 Polypeptide and dna thereof useful as a neovascular marker
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269122 Monoclonal antibody fusion comprising cathelicidin which targets microorganiams for destruction; for use in health care, veterinary medicine and food processing
10/30/2008US20080269118 Identifying molecule suitable for treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, by determining whether candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which Gpr100 polypeptide comprises specific amino acid sequence
10/30/2008US20080269113 P53 binding t cell receptor molecules
10/30/2008US20080268541 Attenuated Mycobacteria as Vectors for Gene Delivery to Mammalian Cells
10/30/2008US20080268539 Synthesis of Long-Chain Polyunsaturated Fatty Acids by Recombinant Cells
10/30/2008US20080268538 Bioreactor for stable propagation of cells
10/30/2008US20080268537 Free of nitrone; for reducing oxidative damage or delaying senescence
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268535 Culturing OP9 stromal cells lacking macrophage-colony stimulating factor and colony stimulating factor-1 which differentiate embryonic stem cells into cells of various lineages, but express hematopoietic factors, such as stem cell factor and interleukin-6; layering leukemia cells derived from bone marrow
10/30/2008US20080268534 Compositions and methods useful for culturing differentiable cells
10/30/2008US20080268533 Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
10/30/2008US20080268532 Dipeptidyl peptidases
10/30/2008US20080268522 Lentiviral packaging constructs
10/30/2008US20080268514 Liquid matrix dissolved or dissociated in biocompatible solvent and stabilizer in contact without refrigeration for one day
10/30/2008US20080268500 Capable synthesising mono-, bi- and/or tri-cyclic sesquiterpenes having a C2-C7 or a C3-C7 bond, via farnesyl-pyrophosphate precursor; for catalyzing cyclisation to the santalene and bergamotene carbon skeletons
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268490 Methods for in vitro growth of hair follicles
10/30/2008US20080268470 Methods of selecting cell clones
10/30/2008US20080268467 Using chromodomain ( MRG15 protein) repressor complex to identify modulators for treatment and prevention of viral, cardiovascular, nervous system, autoimmune and liver disorders
10/30/2008US20080268459 Immunoglobulin for use in diagnosis and treatment of cell proliferative disorders; antitumor agents; immunodiagnostics
10/30/2008US20080268448 Multiplex compositions and methods for quantification of human nuclear DNA and human male DNA and detection of PCR inhibitors
10/30/2008US20080268445 Rodent model comprising mutation in adenine nucleotide translocator (ANT) gene for use in identifying modulators for prevention and treatment of cardiac disorders
10/30/2008US20080268419 Supplementation for Embryo and/or Cell Manipulation Media
10/30/2008US20080268097 resveratrol; supplementing or adding non fat cocoa solids produced from these beans to a food product
10/30/2008US20080268068 methods and kits for determining the presence or absence of a SPARC promoter mutation indicative of a cancer's resistance or sensitivity to a therapeutic regimen
10/30/2008US20080268054 Dermal derived human stem cells and compositions and methods thereof
10/30/2008US20080268017 Method of producing tissue by placing a molding support within a body cavity
10/30/2008US20080268013 Polyethylene Oxide Polymers Including Anti-Inflammatory Glycodendrons
10/30/2008US20080267994 in vitro culturing; producing immunostimulants for a specific immune response and individuals who suffer from HIV infection, certain cancers, allergies, have received transplants; Acute Myeloid Leukemia cancers treatments, and autoimmune diseases such as Systemic Lupus Erythematosus; anti-viral cytokines
10/30/2008US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection
10/30/2008US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease
10/30/2008US20080267984 Using low density lipoprotein receptor specific immunoglobulin to increase receptor expression on antigen presenting cells; immunotherapy; treating infection, autoimmune, graft vs host and allergic disorders
10/30/2008US20080267976 Optimized Anti-Cd30 Antibodies
10/30/2008US20080267973 Diagnosis and Treatment of Siglec-6 Associated Diseases
10/30/2008US20080267971 Antibodies Directed to Angiopoietin-2 and Uses Thereof
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267961 SOLUBLE ErbB3 AND TREATMENT OF CANCER
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267953 Anti-perp recombinant antibody
10/30/2008US20080267949 Peptides capable of binding to serum proteins
10/30/2008US20080267943 Innate Immune Receptor Directed Biocides
10/30/2008US20080267934 Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
10/30/2008US20080267930 Biological Materials and Uses Thereof
10/30/2008US20080267929 Use of stem cells to generate inner ear cells
10/30/2008US20080267928 Compositions and Methods for Making Insulin-Producing Cells
1 ... 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 ... 1827